Moreover, three recent studies have examined the expression of PD‐L1 in DDEC/UEC and all reported PD‐L1 expression in tumor and/or stromal immune cells in about half of the cases examined, which correlated with MMR deficiency status [34, 35, 36]. Here, CD274 is linked to neoplasm.